Stem cells are referred as undifferentiated cells that have the provision of developing into specialized cells. They provide various advantages to the human body including growth, and repair of muscles, skin, nerves, brains, bones, blood, and other organs. Stem cells can be developed into several cells types in the course of early life cycle and growth period in the human body. Stem cells are of mainly two types including adult stem cells and embryonic stem cells. Adult stem cells consist of mammary, intestinal, hematopoietic, neural, mesenchyme stem cells and more. All stem cells are capable of renewing and dividing themselves into specialized calls, which include skin cells, heart cells, blood cells, neurons and chondrocytes. Stem cell assay is a technique which is used for the qualitative and quantitative analysis of several properties of a stem cell and aimed at examining living cells based on many parameters including size, shape and others. Such assays provide analysis of cellular and biochemical functions with the help of function cells for the diagnostic purpose in several diseases. These assays also help in examining of cell toxicity, proliferation and motility.
According to data published in 2017 by World Health Organization (WHO), around 422 million individuals suffered from diabetes in 2014. Moreover, another estimation of World Health Organisation (WHO), around 1.6 million patients died due to diabetes in 2015 and will be the seventh foremost reason of death worldwide.
Centers for disease control and prevention estimated that around 19.3 million individuals would be diagnosed with cancer disease every year by 2025. It is the second foremost reason of death in the U.S.
Increasing prevalence of chronic disease such as diabetes, cancer and respiratory disease and increasing clinical trials of stem cell-related therapies and its approval by government organization is anticipated to boost the growth of the market. Moreover, increased usage of stem cells assay in the exploration of drug discovery owing to its nonspecializing nature is attributed to positively impact in the market. Moreover, advanced technology in stem cells therapy and rising awareness of patients towards advanced therapies and diagnosing techniques available in the market is predicted to be major reason fueling the growth in the market. Moreover, development of new therapies and research and development done by various government organizations is expected to propel the market growth. Since the last few decades, cell based assay market is rapidly evolving due to its increased applications in pharmaceutical industries. Moreover, easy regulatory policies are attributed to rising in the market growth over the forecast period. However, the high cost of stem cell therapies and instruments might trigger the growth of the market. In addition, there is a shortage of skilled medical doctors across globe that may hamper the market growth. Furthermore, emerging countries are lacking in required infrastructure for such therapies, which are some of the factors anticipated to impede the expansion of stem cell assay market. Moreover, ethical issues related to human embryonic stem cells in several countries are attributed to impede the market growth.
Geographically, the metabolic testing market is segmented on the basis of the region covering North America, Asia Pacific, Europe, and LAMEA. North America is predicted to be dominant in the market owing to several factors including large patient population base and high adoption of advanced technology in the cell based therapies, which is attributed to show positive impact on the market. Furthermore, increasing healthcare investment in developed countries like Canada and U.S. is expected to fuel the market growth.
Europe is expected to be growing in this market due to factors including the rising biotechnology sector and government initiatives to develop better healthcare infrastructure.
Asia-Pacific is expected to be most growing market attributed to the factors like emerging countries India and China are facilitated with developed biotechnology sector and rising healthcare expenses.
A global leader in medical industry “GE Healthcare” acquired a leading health consulting company “Novia Strategies” to integrate the methodologies and provide better healthcare outcomes.
Prominent players in the market are GE Healthcare, Thermo Fisher Scientific, Cell Biolabs, Inc., Hemogenix, Bio-Rad Laboratories, Inc., Bio-Techne Corporation, Cellular Dynamics International Inc., Promega Corporation, Merck KGaA, and STEMCELL Technologies Inc.
oAdult Stem Cells Kits
oMesenchymal Stem Cell Kits
oUmbilical Cord Stem Cell Kits
oInduced Pluripotent Stem Cell Kits (IPSCs)
oNeuronal Stem Cell Kits
oHematopoietic Stem Cell Kits
oHuman Embryonic Stem Cell Kits
oIsolation & Purification
oCell Imaging Systems
oMicro Electrode Arrays
oAutomated Cell Counter
oRegenerative Medicine & Therapy Development
oOrthopaedic & Musculoskeletal Spine
oCentral Nervous System
oDrug Discovery and Development
By End User
oGovernment Research Institutes
oPrivate Research Institutes